Search

Author/Creator Robinson, Giles W

1. MBRS-28. SINGLE-CELL TRANSCRIPTOME ANALYSIS OF MEDULLOBLASTOMA. Issue 2 (22nd June 2018)

Authors:
Hovestadt, Volker; Filbin, Mariella G; Bihannic, Laure; Shaw, McKenzie L; DeWitt, John M; Groves, Andrew; Smith, Kyle S; Hadley, Jennifer; Gajjar, Amar; Robinson, Giles W; Mayr, Lisa; Slavc, Irene; Goumnerova, Liliana; Ligon, Keith L; Suva, Mario L; Northcott, Paul A; Bernstein, Bradley E
Journal:
Neuro-oncology
Issue:
Volume 20:Issue 2(2018)supplement 2
Page Start:
i134
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. MBCL-44. THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (iMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07). Issue 2 (22nd June 2018)

Authors:
Robinson, Giles W; Rudneva, Vasilisa A; Buchhalter, Ivo; Billups, Catherine A; Waszak, Sebastian M; Smith, Kyle; Bowers, Daniel C; Bendel, Anne; Fisher, Paul; Partap, Sonia; Crawford, John; Hassall, Tim; Indelicato, Daniel J; Boop, Frederick; Klimo, Paul; Sabin, Noah D; Patay, Zoltan; Merchant, T...
Journal:
Neuro-oncology
Issue:
Volume 20:Issue 2(2018)supplement 2
Page Start:
i126
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. MBRS-34. MOLECULAR CHARACTERIZATION OF RECURRENT MEDULLOBLASTOMA REVEALS AN UNEXPECTEDLY HIGH INCIDENCE OF SECONDARY MALIGNANCY. Issue 2 (22nd June 2018)

Authors:
Kumar, Rahul; Deng, Maximilian; Rudneva, Vasilisa A; Robinson, Giles W; Dhall, Girish; Klesse, Laure J; Bowers, Daniel C; Chintagumpala, Murali; Leary, Sarah; Orr, Brent A; Pfister, Stefan M; Gajjar, Amar; Jones, David T W; Northcott, Paul A
Journal:
Neuro-oncology
Issue:
Volume 20:Issue 2(2018)supplement 2
Page Start:
i135
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study. Issue 9 (5th April 2021)

Authors:
Khan, Raja B; Patay, Zoltan; Klimo, Paul; Huang, Jie; Kumar, Rahul; Boop, Frederick A; Raches, Darcy; Conklin, Heather M; Sharma, Richa; Simmons, Andrea; Sadighi, Zsila S; Onar-Thomas, Arzu; Gajjar, Amar; Robinson, Giles W
Journal:
Neuro-oncology
Issue:
Volume 23:Issue 9(2021)
Page Start:
1586
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study. Issue 7 (11th December 2021)

Authors:
Lucas, John T; Tinkle, Christopher L; Huang, Jie; Onar-Thomas, Arzu; Srinivasan, Sudharsan; Tumlin, Parker; Becksfort, Jared B; Klimo, Paul; Boop, Frederick A; Robinson, Giles W; Orr, Brent A; Harreld, Julie H; Krasin, Matthew J; Northcott, Paul A; Ellison, David W; Gajjar, Amar; Merchant, Thomas E
Journal:
Neuro-oncology
Issue:
Volume 24:Issue 7(2022)
Page Start:
1166
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. LGG-22. SJ901: Phase I/II evaluation of single agent mirdametinib (PD-0325901), a brain-penetrant MEK1/2 inhibitor, for the treatment of children, adolescents, and young adults with low-grade glioma (LGG). (3rd June 2022)

Authors:
Vinitsky, Anna; Chiang, Jason; Bag, Asim K; Campagne, Olivia; Stewart, Clinton F; Dunphy, Paige; Shulkin, Barry; Li, Qian; Lin, Tong; Hoehn, Mary Ellen; Johnson, Jason N; Towbin, Jeffrey A; Khan, Raja; Tatevossian, Ruth G; Armstrong, Gregory T; Potter, Brian; Conklin, Heather; Shearer, Todd; Scot...
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 1
Page Start:
i92
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. MEDB-69. Clinical and molecular meta-analysis of three major medulloblastoma clinical trials (ACNS0331, SJMB03, ACNS0332) uncovers novel strategies to improve risk-stratified therapy. (3rd June 2022)

Authors:
Smith, Kyle S; Billups, Catherine A; Dhanda, Sandeep K; Bihannic, Laure; Vasilyeva, Aksana; Li, Yimei; Michalski, Jeff M; Olsen, James M; Leary, Sarah; Fouladi, Maryam; Gajjar, Amar; Onar, Arzu; Northcott, Paul A; Robinson, Giles W
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 1
Page Start:
i122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG). Issue 10 (8th April 2022)

Authors:
Desai, Ami V; Robinson, Giles W; Gauvain, Karen; Basu, Ellen M; Macy, Margaret E; Maese, Luke; Whipple, Nicholas S; Sabnis, Amit J; Foster, Jennifer H; Shusterman, Suzanne; Yoon, Janet; Weiss, Brian D; Abdelbaki, Mohamed S; Armstrong, Amy E; Cash, Thomas; Pratilas, Christine A; Corradini, Nadège;...
Journal:
Neuro-oncology
Issue:
Volume 24:Issue 10(2022)
Page Start:
1776
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗